Logo image of ISPC

ISPECIMEN INC (ISPC) Stock Fundamental Analysis

USA - NASDAQ:ISPC - US45032V2079 - Common Stock

1.23 USD
-0.06 (-4.65%)
Last: 10/1/2025, 9:00:59 PM
1.24 USD
+0.01 (+0.81%)
Pre-Market: 10/2/2025, 4:00:58 AM
Fundamental Rating

2

Taking everything into account, ISPC scores 2 out of 10 in our fundamental rating. ISPC was compared to 35 industry peers in the Health Care Technology industry. ISPC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ISPC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ISPC had negative earnings in the past year.
ISPC had a negative operating cash flow in the past year.
In the past 5 years ISPC always reported negative net income.
ISPC had a negative operating cash flow in each of the past 5 years.
ISPC Yearly Net Income VS EBIT VS OCF VS FCFISPC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of ISPC (-168.90%) is worse than 82.86% of its industry peers.
The Return On Equity of ISPC (-1638.63%) is worse than 80.00% of its industry peers.
Industry RankSector Rank
ROA -168.9%
ROE -1638.63%
ROIC N/A
ROA(3y)-81.82%
ROA(5y)-69.08%
ROE(3y)-180.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ISPC Yearly ROA, ROE, ROICISPC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

ISPC's Gross Margin of 32.63% is on the low side compared to the rest of the industry. ISPC is outperformed by 71.43% of its industry peers.
In the last couple of years the Gross Margin of ISPC has declined.
The Profit Margin and Operating Margin are not available for ISPC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.72%
GM growth 5Y-3.19%
ISPC Yearly Profit, Operating, Gross MarginsISPC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

ISPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ISPC has more shares outstanding
The number of shares outstanding for ISPC has been reduced compared to 5 years ago.
ISPC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ISPC Yearly Shares OutstandingISPC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ISPC Yearly Total Debt VS Total AssetsISPC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -22.38, we must say that ISPC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -22.38, ISPC is doing worse than 91.43% of the companies in the same industry.
There is no outstanding debt for ISPC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -22.38
ROIC/WACCN/A
WACC9.75%
ISPC Yearly LT Debt VS Equity VS FCFISPC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.23 indicates that ISPC may have some problems paying its short term obligations.
ISPC's Current ratio of 0.23 is on the low side compared to the rest of the industry. ISPC is outperformed by 85.71% of its industry peers.
A Quick Ratio of 0.23 indicates that ISPC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.23, ISPC is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
ISPC Yearly Current Assets VS Current LiabilitesISPC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.79% over the past year.
Looking at the last year, ISPC shows a very negative growth in Revenue. The Revenue has decreased by -43.78% in the last year.
The Revenue has been growing by 16.66% on average over the past years. This is quite good.
EPS 1Y (TTM)49.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.72%
Revenue 1Y (TTM)-43.78%
Revenue growth 3Y-5.87%
Revenue growth 5Y16.66%
Sales Q2Q%-75.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y10.23%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.76%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ISPC Yearly Revenue VS EstimatesISPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
ISPC Yearly EPS VS EstimatesISPC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ISPC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ISPC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ISPC Price Earnings VS Forward Price EarningsISPC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISPC Per share dataISPC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ISPC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPECIMEN INC

NASDAQ:ISPC (10/1/2025, 9:00:59 PM)

Premarket: 1.24 +0.01 (+0.81%)

1.23

-0.06 (-4.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-14 2025-08-14
Earnings (Next)N/A N/A
Inst Owners1.24%
Inst Owner Change12.27%
Ins Owners0.46%
Ins Owner Change0%
Market Cap6.81M
Analysts82.86
Price TargetN/A
Short Float %33.23%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 10.96
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.57
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS1.07
BVpS0.11
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -168.9%
ROE -1638.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.63%
FCFM N/A
ROA(3y)-81.82%
ROA(5y)-69.08%
ROE(3y)-180.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.72%
GM growth 5Y-3.19%
F-Score3
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.68%
Cap/Sales 3.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z -22.38
F-Score3
WACC9.75%
ROIC/WACCN/A
Cap/Depr(3y)173.33%
Cap/Depr(5y)151.75%
Cap/Sales(3y)28.61%
Cap/Sales(5y)21.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.72%
EPS Next Y10.23%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.78%
Revenue growth 3Y-5.87%
Revenue growth 5Y16.66%
Sales Q2Q%-75.1%
Revenue Next Year11.76%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.02%
OCF growth 3YN/A
OCF growth 5YN/A